Less farmland is going for organic crops as costs and other issues take root
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience.
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience.
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Generate Key Takeaways
SKANEATELES, N.Y. (AP) — Farmer Jeremy Brown taps the nose of a young calf. 'I love the ones with the pink noses,' he says.
This pink-nosed animal is just one of about 3,200 cattle at Twin Birch Dairy in Skaneateles, New York. In Brown's eyes, the cows on the farm aren't just workers: 'They're the boss, they're the queen of the barn.'
Brown, a co-owner at Twin Birch, is outspoken on the importance of sustainability in his operation. The average dairy cow emits as much as 265 pounds (120 kilograms) of methane, a potent climate-warming gas, each year. Brown says Twin Birch has worked hard to cut its planet-warming emissions through a number of environmentally sound choices.
'Ruminants are the solution, not the problem, to climate change,' he said.
___
EDITOR'S NOTE: This story is a collaboration between Rochester Institute of Technology and The Associated Press.
___
Wearing a weathered hoodie and a hat promoting a brand of cow medicine, Brown was spending a windy Friday morning artificially inseminating some of the farm's massive Jerseys and Holsteins. He stepped over an electric manure scraper used to clean the animals' barn.
The electric scraper means the dairy doesn't have to use a fuel-burning machine for that particular job. Twin Birch also recycles manure for use on crops, cools its milk with water that gets recirculated for cows to drink and grows most of its own feed.
Despite all that, the farm has no desire to pursue a U.S. Department of Agriculture organic certification, Brown said. Doing so would add costs and require the farm to forego technology that makes the dairy business, and ultimately the customer's jug of milk, more affordable, he said.
He raises a question many farmers have been asking: Is organic farming just a word?
Declining enthusiasm for the organic certification
An increasing number of American farmers think so. America's certified organic acreage fell almost 11% between 2019 and 2021. Numerous farmers who implement sustainable practices told The Associated Press that they have stayed away from the certification because it's costly, doesn't do enough to combat climate change and appears to be losing cachet in the marketplace. Converting an existing farm from conventional to organic agriculture can cost tens of thousands of dollars and add labor costs.
The rules governing the National Organic Program were published in 2000, and in the years after, organic farming boomed to eventually reach more than 5 million acres. But that has been declining in recent years.
Any downward trend is significant, as organic farms make up less than 1% of the country's total acreage, and organic sales are typically only a tiny share of the nationwide total.
Shannon Ratcliff, a farmer and co-owner of organically certified Shannon Brook Farms in Watkins Glen, New York, attributes the decline to a 2018 fraud case in Iowa involving a farmer selling grain mislabeled as certified organic. 'The whole thing went crazy — work requirements for farmers ramped up and inspection levels were higher,' she said.
It's also just a tough business, Ratcliff said.
Her co-owner, Walter Adam, also thinks younger generations' interest in farming of any kind is also declining.
'It takes six months to learn everything,' Adam said. 'We can't find anybody as willing to work on the farm.'
Adam drives to Manhattan each week to sell their meat and eggs at markets, and spends Sunday mornings helping Ratcliff with business at the Brighton Farmers Market in Brighton, New York.
Frank Mitloehner, a professor in animal science in the College of Agricultural and Environmental Sciences at University of California Davis, said lack of flexibility and efficiency are driving farmers away from organic in an era of rising prices for farmers. He said organic standards need to be overhauled or the marketplace risks organic going away completely.
'I am in awe that so many organic farmers were able to produce that way for that long,' he said. 'It seems that they are losing consumer base in these financially troubling times.'
But the label still matters to some buyers
Still, there are consumers determined to buy organic. Aaron Swindle, a warehouse employee at a chain supermarket, spends every Sunday morning shopping for organic groceries at the Brighton Farmers Market.
'The taste quality is different when it's growing nearby,' Swindle said. He calls the Finger Lakes of New York a 'trifecta,' a region that contributes dairy, produce, and meat for its residents.
John Bolton, owner of Bolton Farms in Hilton, New York, said he has some reservations about organic certification, but he's pursuing it for his hydroponic farm, which grows produce in nutrient-rich water instead of soil. It produces greens such as kale and chard and is popular as a supplier for restaurants in western New York, and draws waves of regular customers at the Rochester Public Market on weekends.
Bolton doesn't use pesticides. On a chilly day this spring, he was at his greenhouse unloading 1,500 ladybugs to do the work of eliminating the operation's aphids. That's the kind of practice organic farms use to earn the certification, he said.
He said his operations aren't immune to the dangers posed by climate change. Abnormally hot days affect their greenhouse, he said: 'It's devastating to not only the people but the plants."
But Bolton described the organic certification as economically and environmentally beneficial to his farm. Getting the certification will carry an expense, but he is confident it will be worth the price.
'It helps with sales. And you feel good about it – you're doing the right practices,' Bolton said.
___
The Associated Press' climate and environmental coverage receives financial support from multiple private foundations. AP is solely responsible for all content. Find AP's standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Post
7 hours ago
- New York Post
Menopause drug might prevent breast cancer and treat hot flashes, research finds
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, 'significantly reduced' breast tissue cell growth, which is a major indicator of cancer progression. Advertisement A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. Advertisement 'The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo,' Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. 5 New research from Northwestern University found that the drug Duavee 'significantly reduced' breast tissue cell growth, a major indicator of cancer progression. Marko Geber – Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. 'This would be expected, as the drug is FDA-approved to treat hot flashes.' Advertisement Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. 5 The women in the study were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Gorodenkoff – 5 Those who took the drug reported fewer hot flashes during the study. fizkes – The findings are preliminary and have not yet been published in a medical journal. Advertisement 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced 'high-risk lesions' — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. 'These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options,' the release stated. Study limitations The researchers said they are 'encouraged' by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. 'Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure,' Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. 5 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' Dr. Swati Kulkarni said. sarayutsridee – Advertisement 'While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk,' he told Fox News Digital. Kabraji also noted that the study focused on reducing levels of one specific protein, 'which does not always predict reduced recurrence of breast cancer.' 'This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer,' he noted. 5 According to Kulkarni,'larger studies with several years of follow-up are needed' to confirm that the drug prevents breast cancer. Science RF – Advertisement 'Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention.' Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. 'Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms,' she added.


Axios
12 hours ago
- Axios
The great poaching: America's brain drain begins
The Trump administration's spending cuts and restrictions on foreign students are triggering a brain drain — and American scientists are panicking. Why it matters: U.S. researchers' fears are coming true. America's science pipeline is drying up, and countries like China are seizing the opportunity to surge ahead. 'This is such a race for being the science powerhouse that you never fully recover,' says Marcia McNutt, president of the National Academy of Sciences. 'You might accelerate back up to 60, but you can't make up for those years when you were at a standstill while the competition was racing ahead.' Driving the news: The National Science Foundation, which funds much of America's fundamental science research, is already doling out grants at its slowest pace in 35 years, The New York Times reports. More cuts to science could come with the "big, beautiful bill." Universities are also watching with bated breath as the administration tries to limit the number of foreign students studying in the U.S.. Harvard is pushing back, but could face a total ban on recruiting internationally. The Trump administration says it will " aggressively revoke" visas for Chinese students studying in "critical fields." By the numbers: While American universities are rescinding offers to incoming PhD students, other countries are recruiting heavily from U.S. labs. The journal Nature analyzed data from its jobs platform to track where scientists are looking for work. In the first few months of the Trump administration, there were jumps in the the number of U.S. applicants looking for jobs in Canada (+41%), Europe (+32%), China (+20%) and other Asian countries (+39%), compared to the same period in 2024. U.S. jobs saw fewer applications from candidates in Canada (–13%) and Europe (–41%). Case in point: France's Aix-Marseille University, which made headlines for earmarking millions of dollars for U.S. scientists, closed its application window after receiving a flood of apps. After American Nobel laureate Ardem Patapoutian's federal grant was frozen, he got an email from China offering 20 years of funding if he relocates his lab, The New York Times' Kate Zernike writes. He declined. 'This is a once-in-a-century brain gain opportunity,' the Australian Strategic Policy Institute wrote in a brief. The other side: The White House argues that its changes to the system will usher in a golden age of science and rebuild public trust. President Trump has also suggested that spots freed up by rejecting international students could be filled by American applicants. But professors say this isn't entirely realistic. "In hard sciences, in astronomy and physics and computer science, for example, there's no way you would fill that hole with local applicants of comparable quality," says Chris Impey, an astronomer at the University of Arizona. What to watch: 'The optimistic part of all of us thinks science is strong enough to outlast one administration, and for a while I thought that, but the hit to young people is at the center of the whole enterprise,' Impey says. 'It's like pulling the rug out from under the whole thing." It's not just brain drain of existing talent, he says. Students who are in high school and college now and thinking about a career in research might reconsider. "There's plenty of things smart kids can do. They don't have to go into science." At the same time, McNutt says she tells students: "If you went into graduate school in the fall of this year, by the time you get your PhD, this madness may be over. You come out with your new PhD ready to fill the gap."
Yahoo
21 hours ago
- Yahoo
Apple Watch 圈圈真的準?美國有研究指 Apple Watch 部份運動數據追蹤表現準度不足
Yahoo購物節,6月2至13日正式舉行!集合全球精選著數的網上大型購物節:波鞋低至36折、手袋低至4折、自助餐半價、旅遊產品買一送一等,更有獨家優惠為您而設,把握限時兩星期優惠,1Click買盡全世界! 早前消委會就發表智能手錶評測報告,強調智能手錶、手環的運動數據都是估算,只適宜作參考之用。其實智能手錶在追蹤不同數據時準度的確存在著誤差。最近美國就有研究指 Apple Watch 於運動時記錄燃燒了多少卡路里的數據,準度並不是想像中的高。 美國密西西比大學的研究人員做了一個關於 Apple Watch 的研究,分析了 56 數據得出一個整合分析,並以 Apple Watch 每一項的表現都與標準的醫療級工具進行了比較。結果顯示 Apple Watch 於測量心率及步數方面極大部份情況下是準確的。研究人員指,測心率與步數的平均絕對百分比誤差(即衡量準確度的標準指標)分別為 4.43% 與 8.17%,然而估算燃燒了卡路里數據表現就達 27.96%。對於一般大眾買到的穿戴式裝置而言,低於 10% 的誤差值表現已被視為「十分優秀」,但研究團隊測試 Apple Watch 在走路、跑步、混合強度訓練和踩單車等多種活動中計算用戶燃燒了多少卡路里的數據時,卻發現其估算值大幅超出可接受範圍。 不過研究人員同時指出,這個數據本身就相當難以估算,因為涉及許多變數如體重及運動方式等等。因此,不要把每個數字都當作 100% 準確,而是可當成其中一種鼓勵的工具,達至恆常運動、保持追蹤習慣並維持動力。團隊還指出,目前 Apple Watch 的準確度已提高了不少,顯示蘋果在硬體及演算法方面都在逐步改進,而指出弱點可幫助開發者獲得更真實的回應建議,協助他們進一步研究,以製出更好的感應器或演算法,提升智能手錶追蹤健康數據的表現。 更多內容: 9to5mac 消委會試智能手錶運動偵測,Garmin 最貴最高分,一款千元級高評分!Apple、Samsung、華為各有高低 智能手錶推薦 2025 | Apple、三星、Garmin 如何選?三鐵、跑山、單車各有不同,睇清楚點揀! 緊貼最新科技資訊、網購優惠,追隨 Yahoo Tech 各大社交平台! 🎉📱 Tech Facebook: 🎉📱 Tech Instagram: 🎉📱 Tech WhatsApp 社群: 🎉📱 Tech WhatsApp 頻道: 🎉📱 Tech Telegram 頻道: